Irritable Bowel Syndrome (IBS) in Pharmacy Settings: How Does it Present and First Line Management
gastroenterologist at University College London Hospitals and the National Hospital for Neurology and Neurosurgery
(Queen Square). In this webinar, Professor Emmanuel summarises the multi-factorial pathophysiology of irritable
bowel syndrome (IBS) and discusses the potential role of probiotics as part of the management of IBS symptoms,
including an overview the clinical evidence of the Bifidobacterium longum 35624™ probiotic strain. Alongside
reflections of his own clinical experience with individuals with IBS, Professor Emmanuel provides practical tips for
communicating with individuals regarding their symptoms and management approaches in the pharmacy setting.
Learning Objectives:
1. Understand why IBS has been reclassified as a disorder of gut-brain interaction and the implications for this when advising individuals seeking advice in pharmacy settings2. Understand the multi-factorial pathophysiology of IBS including the role of the gut microbiome3. Understand the role of specific probiotics as part of the management of IBS and how to communicate thisinformation to individuals seeking advice in pharmacy settings
Recommended for you…
CPD e-learning
0.5 CPD learning hour
CPD e-learning
1 CPD learning hour
Webinar on Demand
0.5 CPD learning hour
Clinical Summary
~5 minute read